Cargando…

Intranasal SARS-CoV-2 Vaccines: Indispensable and Inevitable

Detalles Bibliográficos
Autores principales:	Adashi, Eli Y., Gruppuso, Philip A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal of Preventive Medicine. Published by Elsevier Inc. 2022
Materias:	Current Issues
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271463/ https://www.ncbi.nlm.nih.gov/pubmed/35906142 http://dx.doi.org/10.1016/j.amepre.2022.06.009

Ejemplares similares

SARS-CoV-2 Vaccines: The Mucosal Immunity Imperative
por: Adashi, Eli Y., et al.
Publicado: (2022)

Failing Grade: The Pandemic Legacy of HHS
por: Adashi, Eli Y., et al.
Publicado: (2023)

Addiction Medicine After COVID-19: The Imperative of a Trained Workforce
por: Wu, Joseph H., et al.
Publicado: (2021)

Long COVID: An inevitable sequela of SARS-CoV-2 infection
por: Lai, Chih-Cheng, et al.
Publicado: (2023)

Inevitable future: space colonization beyond Earth with microbes first
por: Lopez, Jose V, et al.
Publicado: (2019)

Cardiovascular disorders followed by SARS-CoV-2 infection: An inevitable challenge – Correspondence()
por: Rouhani, Jalil, et al.
Publicado: (2022)

Severity predictors in pediatric SARS-CoV-2 and MIS-C
por: Zachariah, Philip
Publicado: (2021)

Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer
por: Barrière, Jérôme, et al.
Publicado: (2021)

Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties
por: Smit, Cornelis, et al.
Publicado: (2020)

SARS-CoV-2 challenge studies: ethics and risk minimisation
por: Bull, Susan, et al.
Publicado: (2021)

An intranasal ASO therapeutic targeting SARS-CoV-2
por: Zhu, Chi, et al.
Publicado: (2022)

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
por: Hassan, Ahmed O., et al.
Publicado: (2021)

An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2
por: Thapa, Himadri B., et al.
Publicado: (2021)

Tele-health in neurology: an indispensable tool in the management of the SARS-CoV-2 epidemic
por: Capra, Ruggero, et al.
Publicado: (2020)

Reducing transmission of SARS-CoV-2 with intranasal prophylaxis
por: Boiardi, Federico, et al.
Publicado: (2020)

SARS-CoV-2 outbreak on the Caribbean islands of the Dutch Kingdom: a unique challenge
por: Maria, Priscilla, et al.
Publicado: (2020)

Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
por: Facente, Shelley N., et al.
Publicado: (2021)

Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2
por: Abdoli, Mohsen, et al.
Publicado: (2022)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
por: Chavda, Vivek P., et al.
Publicado: (2021)

Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys
por: Le Nouën, Cyril, et al.
Publicado: (2022)

The Impact of the Highly Virulent SARS-CoV-2 Gamma Variant on Young Adults in the State of São Paulo: Was It Inevitable?
por: Spira, Beny
Publicado: (2022)

DockCoV2: a drug database against SARS-CoV-2
por: Chen, Ting-Fu, et al.
Publicado: (2020)

Intravenous, Intratracheal, and Intranasal Inoculation of Swine with SARS-CoV-2
por: Buckley, Alexandra, et al.
Publicado: (2021)

Attitudes of vaccination service providers to the SARS-CoV-2 intranasal spray vaccine during the SARS-CoV-2 pandemic in China: A cross-sectional study
por: Cao, Yanlin, et al.
Publicado: (2023)

Cytotoxic Lesion of the Corpus Callosum (CLOCCs) after SARS-CoV-2 mRNA Vaccination
por: Youn, Taeho, et al.
Publicado: (2021)

T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations
por: Nersisyan, Stepan, et al.
Publicado: (2021)

To breastfeed or not to breastfeed? Lack of evidence on the presence of SARS-CoV-2 in breastmilk of pregnant women with COVID-19
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2020)

Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
por: Mansi, Laura, et al.
Publicado: (2021)

Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
por: An, Xingyue, et al.
Publicado: (2021)

Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges
por: Kar, Sanchita, et al.
Publicado: (2022)

Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques
por: Nouën, Cyril Le, et al.
Publicado: (2022)

Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection
por: Baldeon Vaca, Gabriela, et al.
Publicado: (2023)

Genome-Wide Analysis of the Indispensable Role of Non-structural Proteins in the Replication of SARS-CoV-2
por: Jin, Yunyun, et al.
Publicado: (2022)

Polymeric Materials as Indispensable Tools to Fight RNA Viruses: SARS-CoV-2 and Influenza A
por: Santos, Ariana C. F., et al.
Publicado: (2022)

Intranasal gene therapy to prevent infection by SARS-CoV-2 variants
por: Sims, Joshua J., et al.
Publicado: (2021)

Safety of intranasal corticosteroids in acute rhinosinusitis
por: Demoly, Pascal
Publicado: (2008)

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models
por: Ku, Min-Wen, et al.
Publicado: (2021)

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models
por: Zhou, Runhong, et al.
Publicado: (2021)

Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy
por: Christensen, Dennis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uk876t0ratd0lqudfsil355e3h